Latest filing published 08 Aug 2024 for Aurinia Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Scott Habig: trading record in brief
All filings by Scott Habig on record concern Aurinia Pharmaceuticals Inc. Between 18 July 2022 and 6 August 2024, the trades on record add up to 4 filings.
Every open-market trade on record is a purchase: 1 purchase worth €19k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises.
On 8 August 2024 came the latest disclosure, an option exercise in Aurinia Pharmaceuticals Inc. The last purchase on record was published on 15 November 2022, which is 1,456 days ago. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Scott Habig
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,595 sharesCommon SharesTSXSEDI:4358645
- 29,976 sharesCommon SharesTSXSEDI:4263298
- Common SharesTSXSEDI:4029674
- 5,000 shares@ CA$5.015Common SharesTSXSEDI:4029676Canonical exit: 7 Feb 2023 (T+90)
4 of 4 declarations